Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2008 May 20;75(1):82–83. doi: 10.1007/s12098-008-0014-9

Persistent thrombocytopenia following dengue shock syndrome

Utkarsh Kohli 1, Sunil Saharan 1, Rakesh Lodha 1,, S K Kabra 1
PMCID: PMC7101604  PMID: 18245943

Abstract

Though thrombocytopenia is one of the hallmarks of dengue hemorrhagic fever/ dengue shock syndrome, persistence of the same is rare. We report an 11 year-old child with dengue shock syndrome, who developed persistent thrombocytopenia. The possible mechanisms are discussed.

Key words: Thrombocytopenia, Dengue shock syndrome

References

  • 1.Rigau-Perez J.G., Clark G.C., Gubler D.J., Reiter P., Sanders E.J., Vorndam A.V. Dengue and dengue hemorrhagic fever. Lancet. 1998;352:971–977. doi: 10.1016/S0140-6736(97)12483-7. [DOI] [PubMed] [Google Scholar]
  • 2.Ratageri V.H., Shepur T.A., Wari P.K., Chavan S.C., Mujahid I.B., Yergolkar P. Clinical profile and outcome of dengue fever cases. Indian J Pediatr. 2005;72:705–706. doi: 10.1007/BF02724083. [DOI] [PubMed] [Google Scholar]
  • 3.Kamil S.M., Mohamad N.H., Narazah M.Y., Khan F.A. Dengue hemorrhagic fever with unusual prolonged thrombocytopenia. Singapore Med J. 2006;47:332–334. [PubMed] [Google Scholar]
  • 4.Leong K.W., Srinivas P. Corticosteroid-responsive prolonged thrombocytopenia following dengue hemorrhagic fever. Med J Malaysia. 1993;48:369–372. [PubMed] [Google Scholar]
  • 5.Nimmannitya S. Monograph on dengue/dengue hemorrhagic fever. New Delhi: World Health Organization; 1993. Clinical manifestations of dengue/dengue hemorrhagic fever; pp. 48–54. [Google Scholar]
  • 6.Saito M., Oishi K., Inoue S., Dimaano E.M., Alera M.T., Robles A.M., et al. Association of increased platelet associated immunoglobulins with thrombocytopenia and severity of disease in secondary dengue virus infections. Clin Exp Immunol. 2004;138:299–303. doi: 10.1111/j.1365-2249.2004.02626.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.La Russa V.F., Innis B.L. Mechanism of dengue virus-induced bone marrow suppression. Bailliers Clin Hematol. 1995;8:249–270. doi: 10.1016/S0950-3536(05)80240-9. [DOI] [PubMed] [Google Scholar]
  • 8.Butthep P., Bunyaratvej A., Bhamarapravati N. Dengue virus and endothelial cell: a related phenomenon to thrombocytopenia and granulocytopenia in dengue hemorrhagic fever. Southeast Asian J Trop Med Public Health. 1993;24:246–249. [PubMed] [Google Scholar]
  • 9.Ascher D.P., Laws H.F., Hayes C.G. The use of intravenous gammaglobulin in dengue fever, a case report. Southeast Asian J Trop Med Public Health. 1989;20:549–554. [PubMed] [Google Scholar]
  • 10.Schexneider K.I., Reedy E.A. Thrombocytopenia in dengue fever. Curr Hematol Rep. 2005;4:145–148. [PubMed] [Google Scholar]

Articles from Indian Journal of Pediatrics are provided here courtesy of Nature Publishing Group

RESOURCES